Cigna shares conservative 2026 outlook as medical costs weigh on margins
The health insurer expects 2026 profit to fall short of analyst estimates as medical costs rise. Strong pharmacy growth helped exceed fourth quarter earnings.
Insights:
Cigna Corporation announced on Thursday, February 5, 2026, that its projected revenue and profit for 2026 are expected to fall below current Wall Street expectations. The company, based in the US 
US, cited persistent medical cost and margin pressures as the primary drivers behind the lower-than-anticipated guidance. This announcement comes despite recent operational growth within its key segments, marking a cautious outlook for the coming fiscal year.
US, cited persistent medical cost and margin pressures as the primary drivers behind the lower-than-anticipated guidance. This announcement comes despite recent operational growth within its key segments, marking a cautious outlook for the coming fiscal year.According to the guidance released today, Cigna Corporation forecasts adjusted revenue of approximately $280 billion for 2026, with adjusted profit per share expected to be at least $30.25. These figures trail the estimates previously set by analysts, who had projected revenue of $283.86 billion and an adjusted earnings per share (EPS) of $30.36. This gap highlights the lowered expectations for the financial performance of Cigna Corporation in the 2026 period.
